Key result
SEA0400 (1 microM) inhibited the NCX current by >80% without significantly affecting other membrane currents, demonstrating 10-fold higher potency and greater selectivity than KB-R7943.
Answers are grounded in this paper and cite their sources.
SEA0400 is a potent and highly selective inhibitor of the Na(+)-Ca(2+) exchanger, providing a powerful tool for studying the role of NCX in the heart.
The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943). SEA0400 concentration-dependently inhibited the NCX current with a 10 fold higher potency than that of KB-R7943; 1 microM SEA0400 and 10 microM KB-R7943 inhibited the NCX current by more than 80%. KB-R7943, at 10 microM, inhibited the sodium current, L-type calcium current, delayed rectifier potassium current and inwardly rectifying potassium current by more than 50%, but SEA0400 (1 microM) had no significant effect on these currents. These results indicate that SEA0400 is a potent and highly selective inhibitor of NCX, and would be a powerful tool for further studies on the role of NCX in the heart and the therapeutic potential of its inhibition.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2002) studied this question. SEA0400 vs. KB-R7943 (10 microM) was evaluated on NCX current inhibition. SEA0400 (1 microM) inhibited the NCX current by >80% without significantly affecting other membrane currents, demonstrating 10-fold higher potency and greater selectivity than KB-R7943.
Synapse has enriched 10 related papers. Consider them for comparative context: